अApnaFunda

S.J.S. ENTERPRISES LIMITED (SJS)

Producer Manufacturing · Auto Parts: OEM · figures to Nov '26

Quality scoreHow the business itself ranks against its sector peers on profitability, 3-year growth and leverage. 50 is the middle of the sector.93 / 100
Profitability 92Growth 88Balance sheet 100
Momentum scoreHow strong the recent trend is: 3-month price change, 12-month improvement in earnings and the rise in FII + DII holding, among companies above ₹500 cr.68 / 100
Price 29Earnings 82FII/DII 94

Passes these screensQuality CompounderDebt-light & profitableConsistent compounders

Share price

Closing priceAdjusted for splits and bonus issues.

₹2,052.8 latest close · −6.2% over the last 90 sessions

₹2,000₹2,250₹2,500Jul 3Jul 29Aug 24Sep 17Oct 14Nov 9 ₹2,000₹2,250₹2,500Jul 3Sep 4Nov 9

₹2,052.8 month-end · +21.1% over 12 months

₹1,500₹2,000₹2,500Nov '25Jan '26Apr '26Jun '26Sep '26Nov '26 ₹1,500₹2,000₹2,500Nov '25May '26Nov '26

₹2,052.8 month-end · +225.5% over 3 years

₹1,000₹2,000Nov '23Jun '24Jan '25Sep '25Apr '26Nov '26 ₹1,000₹2,000Nov '23May '25Nov '26

₹2,052.8 month-end · +329.4% since Jun '22

₹1,000₹2,000Jun '22May '23Mar '24Feb '25Dec '25Nov '26 ₹1,000₹2,000Jun '22Sep '24Nov '26

52-week range ₹1503.00 to ₹2590.00 · 1-year volatility 38.2%

Was the rally earned?

+21%share price, 1 yearLower P/E held it back

Mostly yes, with a catch.

  • Per-share earnings added 56 points, but investors now pay less per rupee of profit (P/E 42.5x to 31.1x), which took 34 points back.
  • The share count rose 2%.
Net profit growth: +58 pts. Points of the price return explained by net profit growing (or shrinking).+58 ptsNet profit growthP/E change: −34 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.−34 ptsP/E changeShare count change: −2 pts. Points of the price return explained by the share count changing. More shares count against the price.−2 ptsShare count changeShare price: +21%+21%Share priceNet profit growth: +58 pts. Points of the price return explained by net profit growing (or shrinking).+58ProfitP/E change: −34 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.−34P/EShare count change: −2 pts. Points of the price return explained by the share count changing. More shares count against the price.−2SharesShare price: +21%+21%Share price
Net profit growth+58 ptsNet profit rose about 69%, which lifts the price.
P/E change-34 ptsThe P/E fell from 42.5x to 31.1x, which lowers the price.
Share count change-2 ptsShare count rose 2%, which lowers the price.
+226%share price, 3 yearsEarnings-driven

Mostly yes.

  • Per-share earnings added 209 points to the rise, while the multiple moved less (P/E 28.5x to 31.1x).
  • The share count rose 6%.
Net profit growth: +221 pts. Points of the price return explained by net profit growing (or shrinking).+221 ptsNet profit growthP/E change: +16 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.+16 ptsP/E changeShare count change: −12 pts. Points of the price return explained by the share count changing. More shares count against the price.−12 ptsShare count changeShare price: +226%+226%Share priceNet profit growth: +221 pts. Points of the price return explained by net profit growing (or shrinking).+221ProfitP/E change: +16 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.+16P/EShare count change: −12 pts. Points of the price return explained by the share count changing. More shares count against the price.−12SharesShare price: +226%+226%Share price
Net profit growth+221 ptsNet profit rose about 218%, which lifts the price.
P/E change+16 ptsThe P/E rose from 28.5x to 31.1x, which lifts the price.
Share count change-12 ptsShare count rose 6%, which lowers the price.
What do "pts" mean?

"pts" are percentage points of the share price return. The parts add up to the total shown for each period. Because price = P/E × net profit ÷ share count, higher profit pushes the price up, a higher P/E pushes it up, and more shares push it down.

Example: if the price rose 34% and profit growth accounts for +58 pts while a lower P/E accounts for -24 pts, then 58 - 24 = 34. The +58 is not the profit growth rate itself: it is the part of the price move that profit growth explains.

Not shown for 5 years: earnings were negative at one end, or there is not enough history.

Net profit is trailing twelve months as reported with a 60-day lag.

Compare this with SAMVARDHANA MOTHERSON INT

How rough has the ride been?

Maximum drawdown-37.2%recovered 2025-08
1-year volatility38.2%annualised
Beta vs sector index0.963-year daily, correlation 0.48
Volume spikes2last 90 sessions, 5x the 50-day median

Drawdown from peak

0%−20%−40%20222023202420252026−37.1% 0%−20%−40%20242026−37.1%
Largest drawdowns

-37.2% (2024-12 peak to 2025-03 low, recovered 2025-08)

-33.9% (2021-11 peak to 2021-12 low, recovered 2022-09)

-26.9% (2026-08 peak to 2026-10 low, not yet recovered)

Most recent volume spikes

2026-09-18: 8.1x the 50-day median, price +6.9% that day

2026-08-14: 5.3x the 50-day median, price +5.3% that day

Beta is the slope of daily returns against a market-cap-weighted index of the sector's other listed companies, built from today's constituents (so it excludes companies no longer listed).

Is it expensive against its own past and its peers?

31.1xP/E todayWithin its usual range
Against its own history56th percentile
CheapestMedian 30.9xDearest

Usual range 25.1x to 40.9x since 2022-06.

Against Producer Manufacturing31.1x vs 29.6x
This company
31.1x
Sector median
29.6x

5% above the Producer Manufacturing median.

21.9x30.0x38.1x46.2xJun '22May '23Apr '24Mar '25Feb '26Nov '2621.9x30.0x38.1x46.2xJun '22Dec '23Jun '25Nov '26
P/E (this company)10th to 90th percentile of its own historyIts medianProducer Manufacturing median

The chart loads when you open this tab.

P/B (this company)10th to 90th percentile of its own historyIts medianProducer Manufacturing median

The chart loads when you open this tab.

P/S (this company)10th to 90th percentile of its own historyIts medianProducer Manufacturing median
How to read this

Shaded band: 10th to 90th percentile of the company's own P/E history; dotted line: its median; orange line: sector median (companies with a positive multiple, at least 5 in the sector).

Sector figures are built from today's listed companies, so they exclude companies that are no longer listed.

All terms explained in the glossary →

How Producer Manufacturing is valued

Where does it rank among Producer Manufacturing peers?

Each cell is the company's percentile rank among its Producer Manufacturing peers (non-financial companies) that month.
Darker is better-ranked.
Rows marked ↓ are inverted (lower debt, shorter cash cycle and a lower P/E rank higher).

Where it ranks today

  • ROCE87th▲ 11 pts vs a year ago
  • Op. margin97thflat vs a year ago
  • Revenue growth78th▲ 20 pts vs a year ago
  • EPS growth82nd▲ 4 pts vs a year ago
  • Debt/equity ↓82nd▲ 7 pts vs a year ago
  • Cash cycle ↓62ndflat vs a year ago
  • P/E ↓48th▲ 11 pts vs a year ago
  • 12M momentum74th▼ 16 pts vs a year ago

Rank history

ROCE
Op. margin
Revenue growth
EPS growth
Debt/equity ↓
Cash cycle ↓
P/E ↓
12M momentum
Dec '21Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25Jul '25Jan '26Jul '26Nov '26
Lower rank Higher rank Not enough data

Percentiles use today's listed companies in the sector and need at least 5 peers with a value; grey cells have too few.
ROE is computed from net profit and book value where the source does not report it.

The Producer Manufacturing sector page Watch it move against Producer Manufacturing in the Observatory

What is the price implying?

~20%annual earnings growth implied by the price

At a P/E of 31.1x, the price would imply about 20.1%/yr earnings growth for 10 years under the same assumptions, but it is not ranked.

Fewer than six years of annual earnings are available, which is too little to measure delivered growth.

“Implied growth” is what the current price would require under our stated assumptions, not what we expect.

What prices imply across Producer Manufacturing The market-wide Expectations lists

Key figures

Share Priceclose 9 Nov
₹2052.80
P/E
31.1x
ROCE
29.0%
Market Cap
₹6619 cr
Revenue (TTM)
₹1007 cr
P/S
6.6x
P/B
7.6x
ROE
24.5%
Operating Margin
29.0%
Debt / Equity
0.0x
Promoter Holding
20.1%
12M Momentum
21.1%

52-week range

₹1503.00₹2590.00
51% of the way from its 52-week low to its high

Price risk

1Y volatility
38.2%
Beta vs sector
1-year daily
0.91

Balance sheet & cash

Interest cover
operating profit ÷ interest
70.5x
Cash from profit, 3Y
operating cash flow ÷ net profit
1.32x
Share count, 1Y
+3.2%

Are profits backed by cash?

6 of 7checks within range1 near a threshold
Other income reliance17%Near threshold

Other income as a share of pre-tax profit (trailing twelve months): 16.8%. Bands: below 15%, 15% to 35%, above 35%.

Tax rate25%Within range

Median quarterly effective tax rate over about 2.5 years: 25.0%. Bands: 15% to 35%, 5% to 15% or 35% to 50%, outside 5% to 50%.

Cash conversion1.32xWithin range

Operating cash flow divided by net profit over the last three fiscal years: 1.32x (cash from operations ₹496 cr, net profit ₹376 cr). Bands: 0.8x and above, 0.5x to 0.8x, below 0.5x.

Free cash flow5 of 5 yrsWithin range

Fiscal years with positive free cash flow in the last 5: 5. Bands: at least 80% of years, 40% to 80%, below 40%.

Receivable days vs history+1 daysWithin range

Debtor days are above the median of the previous three fiscal years by 1 days (85 vs 84). Bands: under 15 days, 15 to 45, over 45.

Capital work in progress15% of fixed assetsWithin range

Capital work-in-progress is 15% of fixed assets. Bands: not rising or up to 30%; rising for three years and above 30%; rising and above 60%.

Payable days+2 days / 2 yrsWithin range

Days payable changed by +2 over two years. Bands: rise of up to 30 days; more than 30 days.

Tap a check to see how it is measured

How to read this

Each check is a named rule with fixed thresholds, not a score. Annual statements are the latest restated figures, so a past year may differ from what was originally reported.

All terms explained in the glossary →

Who has been buying and selling?

  • Over 3 years, DIIs added 3.5 pts; promoters trimmed 1.7 pts.
  • The number of shareholders rose from 64,873 to 74,050 (+14%) between Sep 2023 and Jun 2026.

Holdings, Jun '26

How each group changed

GroupSep '23Jun '26Change
Promoters21.8%20.1%-1.7 pts
FIIs14.3%14.7%+0.4 pts
DIIs30.5%34.0%+3.5 pts
Public and others33.4%31.1%-2.3 pts

Number of shareholders

74,050shareholders+14% since Sep '23
55k62k69k75k Sep '23Jun '24Mar '25Dec '25Jun '26
Sep '23: 64,873
Dec '23: 65,633
Mar '24: 60,752
Jun '24: 55,009
Sep '24: 55,124
Dec '24: 64,498
Mar '25: 62,920
Jun '25: 65,021
Sep '25: 68,067
Dec '25: 73,463
Mar '26: 75,411
Jun '26: 74,050
55k62k69k75k Sep '23Sep '24Sep '25Jun '26
Sep '23: 64,873
Dec '23: 65,633
Mar '24: 60,752
Jun '24: 55,009
Sep '24: 55,124
Dec '24: 64,498
Mar '25: 62,920
Jun '25: 65,021
Sep '25: 68,067
Dec '25: 73,463
Mar '26: 75,411
Jun '26: 74,050

Quarterly shareholding as reported, labelled by the quarter it covers (it becomes visible about two months later).
Shareholder counts are only available for recent quarters.

This quarter's smart-money board

What happened next to similar setups

−11.6%typical 12-month return vs the marketNot meaningfully different from the base rate
  • We found 50 past situations where a non-financial company looked like S.J.S. ENTERPRISES LIMITED today on valuation, return on capital, margins, debt, growth, price momentum, size and volatility.
  • Over the following 12 months the middle half of them returned −30% to +17% vs the market, against −4% for all non-financial companies in the same months.
  • The gap against the base rate (−7.7%, 80% range −15.5% to +1.0%) is within what chance and overlapping periods produce.

Where the 50 outcomes landed

−60%−40%−20%0%+20%+40%+60%+80%
LUXIND · Nov 2021: −59.4% vs market
LAOPALA · Jun 2023: −49.3% vs market
FDC · Nov 2020: −41.2% vs market
NUCLEUS · Oct 2020: −40.3% vs market
CERA · Oct 2023: −39.2% vs market
KKCL · Aug 2023: −38.6% vs market
RITES · May 2020: −38.1% vs market
BLS · May 2025: −37.2% vs market
KSCL · Aug 2020: −37.2% vs market
CONCORDBIO · Nov 2024: −35.9% vs market
MPSLTD · Apr 2025: −31.7% vs market
EMAMILTD · Mar 2025: −30.3% vs market
ARE&M · Jun 2020: −29.9% vs market
ZTECH · Oct 2025: −29.4% vs market
RSYSTEMS · Dec 2023: −27.9% vs market
ADFFOODS · May 2021: −25.5% vs market
BSOFT · Jul 2021: −22.2% vs market
KSB · Apr 2024: −20.1% vs market
DHANUKA · Dec 2020: −19.6% vs market
CAPLIPOINT · Jan 2025: −19.4% vs market
SUMICHEM · Sep 2025: −19.2% vs market
EIHOTEL · Dec 2024: −16.9% vs market
ECLERX · Mar 2022: −14.0% vs market
ELECON · Feb 2024: −13.8% vs market
NEWGEN · Jul 2024: −12.4% vs market
AIAENG · Jun 2023: −10.9% vs market
SHANTIGEAR · Aug 2023: −10.3% vs market
CENTURYPLY · Jul 2022: −2.9% vs market
AJANTPHARM · Apr 2025: −2.2% vs market
ATUL · Nov 2020: −2.2% vs market
GARFIBRES · Aug 2025: −1.3% vs market
PERSISTENT · Jul 2021: +7.4% vs market
VESUVIUS · Jun 2024: +7.5% vs market
RHIM · Jul 2022: +8.0% vs market
CARERATING · Oct 2025: +9.2% vs market
CARBORUNIV · Jan 2022: +11.1% vs market
YATHARTH · Dec 2024: +14.0% vs market
FINPIPE · Apr 2020: +17.8% vs market
COFORGE · Apr 2021: +18.3% vs market
JBCHEPHARM · Feb 2021: +19.8% vs market
INGERRAND · Jan 2023: +19.8% vs market
ADVENZYMES · Aug 2020: +20.3% vs market
FCL · Apr 2022: +25.4% vs market
SUPRIYA · Aug 2024: +29.7% vs market
BDL · Jun 2022: +37.0% vs market
THYROCARE · Sep 2025: +37.3% vs market
TRITURBINE · Dec 2023: +48.7% vs market
GRINDWELL · Sep 2021: +49.9% vs market
MPHASIS · Feb 2021: +59.8% vs market
KFINTECH · Jun 2024: +88.5% vs market
Similar setups −11.6%All companies −3.9%← worse than the marketbetter than the market →

Each dot is one past situation (hover or tap for details) · Solid dots are the closest matches, listed below · Shaded is the middle half of all companies in the same months · 1 beyond the range shown, drawn at the edge

Similar setups' median
−11.6%
All companies' median
−3.9%
Beat the market
38% vs 46%

50 past situations · 50 companies · 37 months · 2020–2025

The closest matches

CompanyWhenP/EROCE12M mom.DrawdownNext 12 months
ADVENZYMES
Consumer Non-Durables
Aug 2020 17x22% +35%−17% +20%
CARERATING
Commercial Services
Oct 2025 34x25% +10%−17% +9%
VESUVIUS
Non-Energy Minerals
Jun 2024 43x26% +110%−10% +8%
JBCHEPHARM
Health Technology
Feb 2021 32x23% +108%−10% +20%
EIHOTEL
Consumer Services
Dec 2024 40x24% +68%−15% −17%
Show the other 3 matches
CompanyWhenP/EROCE12M mom.DrawdownNext 12 months
BLS
Technology Services
May 2025 37x31% +31%−20% −37%
RHIM
Producer Manufacturing
Jul 2022 31x37% +48%−22% +8%
CONCORDBIO
Health Technology
Nov 2024 36x28% +59%−18% −36%
How reliable is this?

Matched on P/E, P/S, ROCE, operating margin, debt/equity, interest cover, revenue growth, 12-month momentum, drawdown from 12-month high, size and volatility. Closest on: 12-month momentum, drawdown from 12-month high and P/E. One match per company and at most 7 from any one month.

Independent periods: the matches fall in 6 distinct 12-month windows. Matches from nearby months share the same market conditions, so fewer windows means less evidence.

How this is built

This is history, not a forecast. These are past situations where other companies had broadly similar reported numbers and price trends. What happened to them does not tell you what will happen to S.J.S. ENTERPRISES LIMITED. The comparison covers only 2020–2025, a single market period, and only companies still listed today. Companies that were delisted or went bankrupt are missing, which makes past outcomes look better than they were. Returns exclude dividends and are measured against an ApnaFunda-built index, not an official benchmark. Fundamentals are matched on a 60-day assumed reporting lag, not actual announcement dates. Its historical skill has not yet been measured. Past patterns may not repeat.

Methodology

How historical analogs are built

Data as of 2026-11-09. Outcome pool: Jan 2020 to Oct 2025.

For every company we look at the situation it is in today (valuation, return on capital, margins, debt, growth, 12-month price momentum, drawdown, size and volatility) and find past company-months that looked most like it. We then show what happened to those past situations over the following 12 months, measured against the ApnaFunda All index and against the base rate. It describes history. It does not predict anything.

What is compared

FeatureWeightNon-financialFinancial
P/E1yesyes
P/S1yes—
P/B1—yes
ROCE1yes—
operating margin1yes—
ROE1—yes
debt/equity0.75yes—
interest cover0.5yes—
revenue growth0.75yesyes
12-month momentum1yesyes
drawdown from 12-month high0.75yesyes
size0.75yesyes
volatility0.5yesyes

Weights were set by judgement before any outcome was looked at and are never tuned on results. Loss-making companies (negative P/E or net profit) are only matched with other loss-making companies. Banks, NBFCs and insurers are compared only with each other and use a different feature set. Every feature is converted, month by month, to its rank among companies in the same pool in that month, so a P/E of 30 in a hot market and a P/E of 22 in a cold one can match if both were equally expensive for their time. Only that month's data is used.

How closeness and the sample are defined

Distance is the weighted root-mean-square gap between the standardised features both companies have. A match needs at least 70% of the query's feature weight, a distance of at most 0.9, and 30 matches at minimum to be shown. We keep up to 50 matches with these exclusions: never the company itself, one match per company (its closest month), and at most 7 from any one calendar month so a single market episode cannot dominate.

Base rate

The base rate is the distribution of 12-month returns, relative to the market, of every eligible company-month in the same pool, with each month weighted to match the months the analogs came from. It answers: how did a random company do in these same months? Because matches from nearby months share the same market conditions, we also report the number of distinct 12-month windows behind a result, and a bootstrap that resamples months decides whether the analog median differs from the base rate at all. "Not meaningfully different" is the usual outcome and the page copy is written for it.

Limits you should know

  • One market period. The outcome pool covers 2020–2025 only (70 months), including the 2020 crash and the 2020–21 rally.
  • Survivorship. Only companies listed today are included. Delisted and bankrupt companies are missing, which flatters past outcomes, particularly for distressed-looking setups.
  • Price return only. Dividends are excluded, and the benchmark is an ApnaFunda market-cap-weighted index of the same listed companies, not an official index.
  • Reporting lag. Fundamentals are matched on an assumed 60-day lag after the quarter end, not on real announcement dates.
  • Pools: non-financial: 98,395 company-months from 2019 companies; financial: 5,659 company-months from 108 companies. 2349 companies currently have a result; the rest are suppressed because too few comparable situations exist.

Does it work? A walk-forward check

The walk-forward check has not been run for this build, so skill is shown as not yet measured.

Disclaimer

This is history, not a forecast. These are past situations where other companies had broadly similar reported numbers and price trends. What happened to them does not tell you what will happen to any company shown. The comparison covers only 2020–2025, a single market period, and only companies still listed today. Companies that were delisted or went bankrupt are missing, which makes past outcomes look better than they were. Returns exclude dividends and are measured against an ApnaFunda-built index, not an official benchmark. Fundamentals are matched on a 60-day assumed reporting lag, not actual announcement dates. Its historical skill has not yet been measured. Past patterns may not repeat.

What else looks like this?

Companies with the most similar financial profile today, regardless of industry.

Technology Services
71%similar
ROCEpromoter holding
CARE RATINGSCARERATING
Commercial Services
68%similar
debt/equityoperating margin
Technology Services
64%similar
promoter holdingdebt/equity
Health Technology
62%similar
EPS growthROCE
Finance
62%similar
revenue growthvolatility
Producer Manufacturing
67%similar
P/EROCE
Producer Manufacturing
56%similar
P/Epromoter holding
Producer Manufacturing
47%similar
volatilityrevenue

Similarity is statistical, based on reported metrics; it does not imply similar business quality or future returns.

What changed?

30 events since Sep '22

  1. OctPriceFell 27% from the Aug 2026 peak to the Oct 2026 low.
  2. SepPriceVolume reached 8.1x its 50-day median on 2026-09-18; price +6.9% that day.
  3. JunPeer rankMoved into the top quartile of Producer Manufacturing on ROCE (from the 2nd quartile).
  4. MayPriceVolume reached 5.7x its 50-day median on 2026-05-07; price +2.4% that day.
  5. MarPeer rankSlipped to the 2nd quartile of Producer Manufacturing on ROCE (from the top quartile).
  6. FebValuationP/E crossed above the 90th percentile of its own history to date (39.8x).
  7. NovPriceVolume reached 21.9x its 50-day median on 2025-11-04; price +6.0% that day.
  8. AugPriceRegained the 2024-12 peak, 5 months after the low.
Show 22 earlier events
  1. AugPriceVolume reached 10.8x its 50-day median on 2025-08-19; price +7.5% that day.
  2. JunValuationP/E crossed above the 90th percentile of its own history to date (34.0x).
  3. JunPeer rankMoved into the top quartile of Producer Manufacturing on ROCE (from the 2nd quartile).
  4. MayPriceVolume reached 13.4x its 50-day median on 2025-05-09; price +10.4% that day.
  5. MarPriceFell 37% from the Dec 2024 peak to the Mar 2025 low.
  6. OctPriceVolume reached 10.3x its 50-day median on 2024-10-14; price +9.7% that day.
  7. AugPriceVolume reached 31.6x its 50-day median on 2024-08-02; price +16.3% that day.
  8. JulValuationP/E crossed above the 90th percentile of its own history to date (31.9x).
  9. JunResultsRevenue (TTM) reached a new high of ₹628 cr.
  10. JunDividendStarted paying a dividend (payout 7% of profit).
  11. MayPriceVolume reached 25.1x its 50-day median on 2024-05-21; price +8.6% that day.
  12. NovPriceVolume reached 6.4x its 50-day median on 2023-11-08; price -8.1% that day.
  13. AugPriceVolume reached 97.2x its 50-day median on 2023-08-22; price +3.3% that day.
  14. JunResultsRevenue (TTM) reached a new high of ₹433 cr.
  15. JunPriceRegained the 2022-09 peak, 3 months after the low.
  16. JunDividendDividend payout cut from 20% to 0% of profit.
  17. JunPriceVolume reached 26.5x its 50-day median on 2023-06-01; price +11.6% that day.
  18. MarPriceFell 26% from the Sep 2022 peak to the Mar 2023 low.
  19. FebPriceVolume reached 8.7x its 50-day median on 2023-02-10; price -7.1% that day.
  20. DecPriceVolume reached 6.0x its 50-day median on 2022-12-13; price +3.4% that day.
  21. SepPriceRegained the 2021-11 peak, 9 months after the low.
  22. SepPriceVolume reached 8.7x its 50-day median on 2022-09-02; price +6.0% that day.

Events are generated from the data by fixed rules.
The month shown is when the change became visible in the reported figures, assuming a 60-day lag after each quarter end; it is not an announcement date.

Where price and fundamentals disagree, market-wide Rewind the whole market to any month

Monthly history54 months · 2022-06 to 2026-11
MonthP/ERevenue (TTM)ROEROCEDebt / Equity
2026-1131.1x₹1007 cr24.5%29.0%0.0x
2026-1031.5x₹1007 cr24.3%29.0%0.0x
2026-0934.2x₹1007 cr24.3%29.0%0.0x
2026-0846.2x₹956 cr19.8%29.0%0.0x
2026-0744.4x₹956 cr19.8%29.0%0.0x
2026-0641.2x₹956 cr19.8%29.0%0.0x
2026-0542.6x₹897 cr23.2%23.0%0.1x
2026-0436.6x₹897 cr23.2%23.0%0.1x
2026-0331.4x₹897 cr23.2%23.0%0.1x
2026-0239.8x₹832 cr20.7%23.0%0.1x
2026-0137.7x₹832 cr20.7%23.0%0.1x
2025-1238.4x₹832 cr20.7%23.0%0.1x
2025-1142.5x₹783 cr18.6%23.0%0.1x
2025-1040.5x₹783 cr18.6%23.0%0.1x
2025-0936.5x₹783 cr18.6%23.0%0.1x
2025-0834.3x₹762 cr17.6%23.0%0.1x
2025-0732.5x₹762 cr17.6%23.0%0.1x
2025-0634.0x₹762 cr17.6%23.0%0.1x
2025-0530.9x₹748 cr20.3%22.0%0.2x
2025-0426.0x₹748 cr20.3%22.0%0.2x
2025-0325.3x₹748 cr20.3%22.0%0.2x
2025-0225.4x₹730 cr19.1%22.0%0.2x
2025-0129.4x₹730 cr19.1%22.0%0.2x
2024-1234.3x₹730 cr19.1%22.0%0.2x
2024-1141.0x₹700 cr17.2%22.0%0.2x
2024-1039.8x₹700 cr17.2%22.0%0.2x
2024-0932.9x₹700 cr17.2%22.0%0.2x
2024-0835.8x₹628 cr15.4%22.0%0.2x
2024-0731.9x₹628 cr15.4%22.0%0.2x
2024-0628.6x₹628 cr15.4%22.0%0.2x
2024-0533.0x₹433 cr15.6%21.0%0.1x
2024-0428.4x₹433 cr15.6%21.0%0.1x
2024-0327.6x₹433 cr15.6%21.0%0.1x
2024-0228.8x₹433 cr15.6%21.0%0.1x
2024-0127.2x₹433 cr15.6%21.0%0.1x
2023-1228.0x₹433 cr15.6%21.0%0.1x
2023-1128.5x₹433 cr15.6%21.0%0.1x
2023-1030.6x₹433 cr15.6%21.0%0.1x
2023-0931.0x₹433 cr15.6%21.0%0.1x
2023-0831.0x₹433 cr15.6%21.0%0.1x
2023-0729.8x₹433 cr15.6%21.0%0.1x
2023-0625.6x₹433 cr15.6%21.0%0.1x
2023-0526.5x₹370 cr15.3%—0.1x
2023-0425.7x₹370 cr15.3%—0.1x
2023-0321.9x₹370 cr15.3%—0.1x
2023-0223.0x₹370 cr15.3%—0.1x
2023-0125.0x₹370 cr15.3%—0.1x
2022-1227.3x₹370 cr15.3%—0.1x
2022-1125.2x₹370 cr15.3%—0.1x
2022-1024.7x₹370 cr15.3%—0.1x
2022-0923.8x₹370 cr15.3%—0.1x
2022-0826.7x₹370 cr15.3%—0.1x
2022-0724.7x₹370 cr15.3%—0.1x
2022-0626.4x₹370 cr15.3%—0.1x

Methodology and data notes

Methodology

Methodology and data notes

All figures come from public exchange prices and screener.in financial statements. Quarterly and annual results are shown from 60 days after the period end, so a month never uses a result before it would plausibly have been published. Statements are the latest versions, which may include later restatements.

Sector medians, percentiles and indices use today's listed companies in the sector (survivorship bias). Prices are adjusted for splits and bonus issues; around a corporate action the fundamentals may lag the price by up to a month, and affected sections are hidden.

The return decomposition uses price = P/E × net profit ÷ share count. The reverse DCF uses a fixed 12% cost of equity, a 10-year horizon and a 15x terminal P/E, and is an illustration only. Events, flags and twins follow fixed rules and thresholds described next to each section.

Feedback